Pain Reliever, Supplement Recall 2022: Products Pulled Over Child Poisoning Risk

Recalls have been issued for pain relief products and dietary supplements by separate manufacturers, which both pose poisoning risks due to improper child-resistant packaging.

The first recall was issued for about 183,000 units of pain relief creams and lotions from Hempväna. The recall affects Hempväna Ultra Strength Pain Relief Cream with Lidocaine, Hempväna Ultra Strength Pain Relief Cream Night with Lidocaine, Hempväna Ultra Strength Pain Relief Cream Turmeric with Lidocaine, and Hempväna Pain Relieving Hand & Body Lotion with Lidocaine.

The recalled creams and lotions were sold nationwide from April 2021 to January 2022 at retailers such as Walmart, Altmeyers, Fred Meyer, Hamricks, Hannaford, Safeway, Rite Aid, CVS, and Boscovs, as well as online at hempvana.com, amazon.com, eBay.com, walmart.com, Altmeyers.com, bedbathhome.com, fredmeyer.com, hamricks.com, hannaford.com, safeway.com, riteaid.com, cvs.com, and boscovs.com.

The affected products, which cost about $20 each, have a UPC number located on the bottom panel of the package, with the lotion products’ UPC located on the label on the back of the packaging. All item numbers and UPC numbers for the recalled creams and lotions can be found here.

According to the recall notice, all of the products contain lidocaine, which must be in a child-resistant package as required by the Poison Prevention Packaging Act. The products were not packaged this way and, as a result, pose a poisoning risk if swallowed or placed on the skin of young children. No reports of incidents or injuries related to the recall have been reported.

Consumers with the affected products in their possession should immediately stop using them or store them in a safe location away from the reach of young children. Contact Telebrands for information on how to safely dispose of the products or how to receive a refund or free child-resistant closure for the jar products. Consumers also can get a $15 digital coupon for their next purchase of Hempväna products at www.Hempvana.com.

Questions about the recall can be directed to Telebrands Corp. at 855-306-1424, Monday through Friday, from 7 a.m. to 12 a.m. ET, Saturday and Sunday from 8 a.m. to 8 p.m. ET, or online at www.hempvana/pages/recall-and-safety or www.hempvana.com by clicking on the “Recall & Safety” button at the bottom of the page for more information.

In a second recall, also for inconsistent child-resistant packaging, Rae Prenatal Capsules and Rae Immunity Capsules have been recalled because they too pose a risk of poisoning young children if ingested. The recall notice states that the products contain iron, which must be in a child-resistant package as required by the Poison Prevention Packaging Act.

The recalled dietary supplements were sold nationwide at Target stores and online at Target.com, ThriveMarket.com, Amazon.com, FabFitFun.com, and StandardDose.com. The Rae Prenatal Capsules were sold from September 2019 to February 2022, and the Rae Immunity Capsules were sold from October 2020 through February 2022. The cost of the products was about $15.

About 191,200 units of the dietary supplement were recalled, which were sold in 60-capsule bottles with “Rae” in yellow lettering and “Prenatal” or “Immunity” printed on the label. The bottles have a white continuous thread closure. No incidents or injuries were reported related to the recall.

Consumers with the recalled dietary supplements in their possession should immediately store the products in a safe location out of the reach of children. They should contact Rae Wellness for information on how to dispose of the product and how to receive a full refund. Consumers can also receive a full refund at the place of purchase, according to the company.

Questions about the recall can be directed to Rae Wellness at 1-888-258-0910, Monday through Friday from 9 a.m. to 5 p.m. CT, or by email at support@raewellness.co or online at www.raewellness.co/update or www.raewellness.com and click on “Important Recall Information.”